Matthew T Conner Selected Research

Matthew T Conner Research Topics

2	Hypoxia (Hypoxemia) 01/2020 - 01/2017
2	Hypothermia 11/2017 - 01/2017
1	Edema (Dropsy) 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Neuromyelitis Optica (Devic's Disease) 03/2019
1	Breast Neoplasms (Breast Cancer) 07/2018
1	Neoplasms (Cancer) 07/2018
1	Temporal Lobe Epilepsy 09/2017
1	Epilepsy (Aura) 09/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Stroke (Strokes) 07/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2015
1	Brain Edema (Cerebral Edema) 07/2015

2	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2020 - 11/2017
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020 - 11/2017
2	Aquaporins (Water Channels)IBA 07/2018 - 09/2017
2	Aquaporin 4IBA 11/2017 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 09/2017 - 01/2017
1	Immunoglobulin G (IgG)IBA 03/2019
1	Aquaporin 3IBA 07/2018
1	Fluorouracil (Carac)FDA LinkGeneric 07/2018
1	AquaglyceroporinsIBA 07/2018
1	Calcium Channels (Calcium Channel)IBA 11/2017
1	CalciumIBA 11/2017
1	EGTA acetoxymethyl esterIBA 11/2017
1	HC-067047IBA 11/2017
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 11/2017

1	Therapeutics 01/2020
1	Induced Hypothermia 01/2017